betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment

RxCUI: 388525
RxNorm name: betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment
Display name: betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment
Full name: betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:22

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 5 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Calcipotriene and Betamethasone Dipropionate	CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE	Padagis Israel Pharmaceuticals Ltd	ba55ff2b-9cfe-40dc-9dac-718cf141c171	2024-04-30	Warnings, Adverse reactions	Exact identifier rxcui: 388525
Calcipotriene and Betamethasone Dipropionate	CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE	Bryant Ranch Prepack	d223e857-590e-48b9-b33e-1275537a508e	2024-02-08	Warnings, Adverse reactions	Exact identifier rxcui: 388525
Calcipotriene and Betamethasone Dipropionate	CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE	Bryant Ranch Prepack	174c5378-f2b9-4e9e-931a-4123137be62d	2023-12-07	Warnings, Adverse reactions	Exact identifier rxcui: 388525
Calcipotriene and Betamethasone Dipropionate	CALCIPOTRIENE, BETAMETHASONE DIPROPIONATE	Bryant Ranch Prepack	d4b301c5-704a-406d-9d9c-74f006334f8a	2023-07-17	Warnings, Adverse reactions	Exact identifier rxcui: 388525
Calcipotriene and Betamethasone Dipropionate	CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE	Prasco Laboratories	d9493e66-251c-426c-90a8-1bf1e526ab85	2022-12-12	Warnings, Adverse reactions	Exact identifier rxcui: 388525

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 6 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
174c5378-f2b9-4e9e-931a-4123137be62d	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment [SY]	5	103	These highlights do not include all the information needed to use CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE OINTMENT safely and effectively. See Full Prescribing Information for CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE OINTMENT . CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE ointment, for topical use Initial U.S. Approval: 2006	20231207
d4b301c5-704a-406d-9d9c-74f006334f8a	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment [SY]	5	103	These highlights do not include all the information needed to use CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE OINTMENT safely and effectively. See Full Prescribing Information for CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE OINTMENT . CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE ointment, for topical use Initial U.S. Approval: 2006	20230717
d223e857-590e-48b9-b33e-1275537a508e	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment [SY]	5	101	These highlights do not include all the information needed to use CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE OINTMENT safely and effectively. See Full Prescribing Information for CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE OINTMENT . CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE ointment, for topical use Initial U.S. Approval: 2006	20240208
ba55ff2b-9cfe-40dc-9dac-718cf141c171	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment [SY]	5	7	These highlights do not include all the information needed to use CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE OINTMENT safely and effectively. See Full Prescribing Information for CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE OINTMENT . CALCIPOTRIENE and BETAMETHASONE DIPROPIONATE ointment, for topical use Initial U.S. Approval: 2006	20240430
d9493e66-251c-426c-90a8-1bf1e526ab85	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment [SY]	5	5	These highlights do not include all the information needed to use Calcipotriene and Betamethasone Dipropionate Ointment safely and effectively. See Full Prescribing Information for Calcipotriene and Betamethasone Dipropionate Ointment. Calcipotriene and Betamethasone Dipropionate Ointment, for topical use Initial U.S. Approval: 2006	20221212
4fe9ed32-0843-4a05-a5f2-d2e6325bbb9a	calcipotriene 0.005 % / betamethasone dipropionate 0.064 % Topical Ointment [PSN] · betamethasone 0.0005 MG/MG / calcipotriene 0.00005 MG/MG Topical Ointment [SCD] · betamethasone 0.05 % (betamethasone dipropionate 0.064 % ) / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.05 % / calcipotriene 0.005 % Topical Ointment [SY] · betamethasone 0.5 MG (betamethasone dipropionate 0.64 MG) / calcipotriene 0.05 MG per GM Topical Ointment [SY]	5	4	These highlights do not include all the information needed to use Taclonex ® Ointment safely and effectively. See Full Prescribing Information for Taclonex ® Ointment. Taclonex ® (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Ointment For topical use only Initial U.S. Approval: 2006.	20120529